|
Extramural Support
|
RMS2014 [E]
|
$298,831,922
|
$73,835
|
N/A
|
National Institutes of Health
|
|
00000000; D.GUY; SEVERABLE OPERATIONS FOR NCI-FREDERICK
|
261200800001E
|
$296,673,020
|
$69,351
|
Heimbrook, David
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-38
|
$7,449,701
|
$223,491
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Regional Oncology Research Center
|
5P30CA006973-51
|
$6,785,409
|
$67,854
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Cancer Center Core Support Grant
|
5P30CA016086-38
|
$6,597,984
|
$329,899
|
SHARPLESS, NORMAN
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
3U01CA121947-08S1
|
$6,300,000
|
$1,575,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
USC Norris Comprehensive Cancer Center (CORE) Support
|
5P30CA014089-39
|
$6,071,261
|
$424,988
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
5P30CA060553-20
|
$4,686,132
|
$93,723
|
PLATANIAS, LEONIDAS
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
Medical Oncology Fellowship Program
|
ZIE BC 010843
|
$4,436,451
|
$221,823
|
Gulley, James
|
CCR (NCI)
|
|
Cancer Center Support Grant
|
2P30CA016042-39
|
$4,295,192
|
$558,375
|
GASSON, JUDITH
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Cancer Center Support Grant-P30
|
5P30CA093373-12
|
$3,044,422
|
$91,333
|
DE VERE WHITE, RALPH
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
Consolidated Basic Cancer Research Program
|
2P30CA010815-45
|
$2,516,380
|
$125,819
|
ALTIERI, DARIO
|
WISTAR INSTITUTE
|
|
AIDS Malignancy Clinical Trials Consortium (AMC)
|
5U01CA121947-08
|
$1,900,000
|
$475,000
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Development of a Vaccine for HIV/AIDS: Humoral Immunity
|
ZIA BC 011058
|
$1,860,026
|
$558,008
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Herpesviral, Oncogenesis, Latency and Reactivation
|
5P01CA019014-35
|
$1,777,079
|
$924,081
|
RAAB-TRAUB, NANCY
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Early Events in KSVH Infection of Primary B-cells
|
5P01CA174439-02
|
$1,771,294
|
$885,647
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses
|
1P01CA177322-01A1
|
$1,732,435
|
$1,732,435
|
SUN, REN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
OHSU Knight Cancer Institute
|
5P30CA069533-17
|
$1,540,000
|
$92,400
|
DRUKER, BRIAN
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-28
|
$1,485,000
|
$89,100
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
JHU ICMIC Program
|
5P50CA103175-09
|
$1,453,060
|
$174,367
|
BHUJWALLA, ZAVER
|
JOHNS HOPKINS UNIVERSITY
|
|
KSHV Persistence and Pathogenesis
|
5P01CA180779-02
|
$1,424,082
|
$712,041
|
JUNG, JAE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,360,387
|
$68,019
|
Oberholtzer, J.
|
CCR (NCI)
|
|
DNA Vaccines
|
ZIA BC 010749
|
$1,095,202
|
$547,601
|
Pavlakis, George
|
CCR (NCI)
|
|
Gene Expression and Post-Transcriptional Regulation of DNA Tumor Viruses
|
ZIA SC 010357
|
$832,381
|
$166,476
|
Zheng, Zhi-Ming
|
CCR (NCI)
|
|
Effects of genetic polymorphism in MHC, KIR, and related loci on human disease
|
ZIA BC 010791
|
$799,639
|
$159,928
|
Carrington, Mary
|
CCR (NCI)
|
|
Clinical Trials of Patients with AIDS-Related Malignancies
|
ZIA BC 010888
|
$780,353
|
$234,106
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Uganda-UCSF Consortium on Prevention and Early Detection of HIV-Associated Cancer
|
1U54CA190153-01
|
$700,186
|
$427,113
|
MARTIN, JEFFREY
|
UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
1U54CA190146-01
|
$700,000
|
$343,000
|
CASPER, COREY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu
|
1U54CA190152-01
|
$697,934
|
$376,884
|
GOPAL, SATISH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Cancer Research International Training and Intervention Consortium (CRITIC)
|
1U54CA190155-01
|
$687,250
|
$213,048
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
Functions of KSHV microRNAs
|
ZIA BC 011176
|
$636,276
|
$318,138
|
Ziegelbauer, Joseph
|
CCR (NCI)
|
|
Rhesus HHV-8 homologue in AIDS-related malignancies
|
5R01CA075922-18
|
$626,541
|
$626,541
|
WONG, SCOTT
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
Improved Diagnosis of Kaposi's Sarcoma Herpes Virus Infection
|
5R44CA134172-04
|
$602,714
|
$602,714
|
DONG, STEVEN
|
EPIPHANY BIOSCIENCES, INC.
|
|
Study of Tumor Pathogenesis and Development of Therapies for AIDS Malignancies
|
ZIA BC 010885
|
$567,530
|
$170,259
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Biostatistics and Data Management Section
|
ZID SC 007202
|
$557,103
|
$27,855
|
Steinberg, Seth
|
CCR (NCI)
|
|
Development of a Vaccine for HIV/AIDS: Cellular Immunity
|
ZIA BC 011062
|
$531,436
|
$175,374
|
Robert-Guroff, Marjorie
|
CCR (NCI)
|
|
Kaposi's sarcoma and human herpesvirus in Africa
|
5R01CA075903-15
|
$521,744
|
$521,744
|
WOOD, CHARLES
|
UNIVERSITY OF NEBRASKA LINCOLN
|
|
Molecular Diagnostics Core Laboratory
|
ZIC BC 011079
|
$512,306
|
$5,123
|
Raffeld, Mark
|
CCR (NCI)
|
|
Cancer risk in solid organ transplant recipients and endstage renal disease
|
ZIA CP010150 - 10362
|
$414,657
|
$41,466
|
Engels, Eric
|
DCEG (NCI)
|
|
ROLE OF Rac AND REACTIVE OXYGEN SPECIES IN KAPOSI'S SARCOMA VIRAL ONCOGENESIS
|
5R01CA136387-05
|
$406,962
|
$406,962
|
MESRI, ENRIQUE
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
Development of a Small Molecule Inhibitor for KSHV LANA
|
1R01CA186775-01
|
$383,875
|
$383,875
|
LIEBERMAN, PAUL
|
WISTAR INSTITUTE
|
|
Genetic and Biochemical Studies of the KSHV LANA Gene
|
5R01CA082036-15
|
$374,795
|
$374,795
|
KAYE, KENNETH
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Viral Oncology Training Grant
|
2T32CA009111-36A1
|
$358,818
|
$35,882
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
Targeting vFLIP for the treatment of KSHV-associated malignancies
|
5R01CA154228-04
|
$340,155
|
$255,116
|
CESARMAN, ETHEL
|
WEILL MEDICAL COLL OF CORNELL UNIV
|
|
Studies of HHV-8 vIL-6 Function
|
5R01CA076445-14
|
$339,078
|
$169,539
|
NICHOLAS, JOHN
|
JOHNS HOPKINS UNIVERSITY
|
|
Training In Tumor Virology
|
5T32CA115299-09
|
$337,821
|
$67,564
|
ROBERTSON, ERLE
|
UNIVERSITY OF PENNSYLVANIA
|
|
Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells
|
ZIA BC 005598
|
$333,231
|
$3,332
|
Gottesman, Michael
|
CCR (NCI)
|
|
Molecular basis for Herpesvirus saimiri oncogenicity
|
5R01CA031363-31
|
$331,599
|
$165,800
|
JUNG, JAE
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Regional Oncology Research Center
|
3P30CA006973-51S3
|
$324,000
|
$3,240
|
NELSON, WILLIAM
|
JOHNS HOPKINS UNIVERSITY
|
|
Kaposi's Sarcoma-associated Herpesvirus Mimics of Cellular microRNAs
|
1R01CA180813-01A1
|
$320,588
|
$320,588
|
GOTTWEIN, EVA
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
Total relevant funding to Kaposi Sarcoma for this search: $24,386,483
|